Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
Why it matters
Novo Nordisk and Eli Lilly's stocks have declined due to Hims & Hers' announcement of a $49 generic version of Wegovy, a significant price drop from the $149 branded pill.
Article tone
Neutral
How the article is written, as reported by the source.
Expected market reaction
Market impact analysis based on bearish sentiment with 90% confidence.
Evidence trail
Evidence
Source
CNBC
Claim
Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
AI inference
Bearish · 90%
Generated
2026-02-05 14:36
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 42067
Original source
Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
Original article published by CNBC on February 5, 2026. Analysis and insights provided by AnalystMarkets AI.